[1] |
SHEN Jiaqing, LIU Yi.
Mechanism of tyrosine kinase 2 inhibitors in treatment of plaque psoriasis and their progress in clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 323-330.
|
[2] |
WANG Hui, XU Xiaofang, LI Rong.
Therapeutic drug monitoring in the individualized administration of cyclosporin A: Application and research progress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 707-713.
|
[3] |
ZHANG Xiaoli, LIU Yi.
Research progress of transient receptor potential ion channels and psoriasis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 469-473.
|
[4] |
CHEN Shengli, LIU Jifeng, SHAN Yunyun.
Effect of Liangxuehuoxue Decoction combined with cupping therapy on plaque psoriasis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 440-445.
|
[5] |
DAI Ying, ZHANG Jing, LIN Mei-qing, SONG Hong-tao.
Research current situation and progress on pharmacogenomics and personalized medicine of cyclosporine A
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 931-936.
|
[6] |
SUN Yu-wen, ZHAO Li-bo, WANG Qian, WEI Zhong-na1, JI Xiang-yong, ZANG Yan-nan, LIU Yang, HUANG Jing, FANG Yi.
Determination of hydrochloric penehyclidine in human plasma and urine by HPLC-MS / MS
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1376-1382.
|
[7] |
MENG Xiang-guang, NI Wen-qiong, WANG Chao, MA Deng-xuan, LI Zhi, ZHOU Hong-hao.
Advances in pharmacogenetics of systemic therapies for psoriasis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(11): 1307-1313.
|
[8] |
MENG Xiang-guang, LI Zhi, WANG Xian-meng, ZHOU Hong-hao.
Advances in Pharmacogenetics of Topical Therapies for Psoriasis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(10): 1179-1184.
|
[9] |
WU Yu-qing, ZHOU Cheng-hua, ZHANG Yong.
Verapamil enhanced the analgesic effect of ketamine in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(11): 1201-1204.
|
[10] |
YU Ai-rong, XIN Hua-wen, WU Xiao-chun. Li Qing.
A cical study on codirtiono of Cyloporin A and beberin hydro-chlride in renal transplanted recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(12): 1415-1418.
|
[11] |
XIAO Mei-fang, ZHANG Xue-mei, BAI Xiang, TAN Huan-ran.
Comparative study on changes of glycogen metabolism in model mice of diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(6): 613-616.
|
[12] |
LI Hao, SUN Jian-Guo, XIE Hai-Tang, WANG Rui, LU Hua, WANG Guang-Ji.
Study on absorption mechanism of ginsenoside Rg1 using rat everted gut sac
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(5): 510-513.
|
[13] |
YU Ai-Rong, WU Xiao-Chun, LI Qing, XIN Hua-Wen, ZHU Min.
Effects of bifendate on the blood concentration and hepatic toxicity of cyclosporine A in renal transplanted recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(5): 548-550.
|
[14] |
WANG Ying-Yan, HUANG Ren, WANG Hui.
Animal models of Alzheimer's disease and their evaluation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(3): 249-252.
|
[15] |
YU Ai-Rong, WU Xiao-Chun, LI Qing, XIN Hua-Wen, ZHONG Ming-Yuan, XIE Sen.
Gender difference of pharmacokinetics of oral cyclosporin A in renal transplanted recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(2): 220-222.
|